EFEMP1 and breast angiosarcoma: A GWAS in a European–American population established an association between EFEMP1 and BA risk in 343 nonsyndromic BA patients and 1716 controls; this finding was validated in an independent European–American cohort comprising 156 patients with BA and other extrahepatic anomalies and 212 controls [21].